GlaxoSmithKline
- Country
- 🇬🇧United Kingdom
- Ownership
- Public
- Established
- 1929-01-01
- Employees
- 70.2K
- Market Cap
- $90B
- Website
- http://www.gsk.com
- Introduction
GSK Plc is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and consumer healthcare products. It operates through the Commercial Operations, and Research and Development segments. The Commercial Operations segment has three product groups of specialty medicines, vaccines, and general medicines. The company was founded in 1715 and is headquartered in Middlesex, the United Kingdom.
Diabetes Study With Rosiglitazone Monotherapy Versus Metformin Or Glyburide/Glibenclamide
- Conditions
- Diabetes Mellitus, Type 2
- First Posted Date
- 2006-01-19
- Last Posted Date
- 2017-11-29
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 4426
- Registration Number
- NCT00279045
- Locations
- 🇬🇧
GSK Investigational Site, Wigan, United Kingdom
Safety Study Using GSK233705 And Tiotropium In Patients With Chronic Obstructive Pulmonary Disease
- Conditions
- Pulmonary Disease, Chronic Obstructive
- Interventions
- First Posted Date
- 2006-01-19
- Last Posted Date
- 2017-09-25
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 31
- Registration Number
- NCT00279019
- Locations
- 🇩🇪
GSK Investigational Site, Berlin, Germany
Active Symptom Control Alone Or In Combination With Oral Topotecan In Patients With Relapsed Resistant Small Cell Lung Cancer
- Conditions
- Lung Cancer, Small Cell
- First Posted Date
- 2006-01-13
- Last Posted Date
- 2013-04-15
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 141
- Registration Number
- NCT00276276
- Locations
- 🇬🇧
GSK Investigational Site, Sutton, Surrey, United Kingdom
An Evaluation Of Mepolizumab In Therapy Of Eosinophilic Oesophagitis In Adult Patients
- Conditions
- Oesophagitis, Eosinophilic
- First Posted Date
- 2006-01-11
- Last Posted Date
- 2016-12-05
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 10
- Registration Number
- NCT00274703
- Locations
- 🇨🇭
GSK Investigational Site, Olten, Switzerland
Post-Operative Nausea And Vomiting Study In Female Patients
- Conditions
- Nausea and Vomiting, PostoperativePostoperative Nausea and Vomiting
- First Posted Date
- 2006-01-11
- Last Posted Date
- 2017-01-20
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 435
- Registration Number
- NCT00274690
- Locations
- 🇬🇧
GSK Investigational Site, Hull, United Kingdom
Depression And Bipolar Disorder
- First Posted Date
- 2006-01-11
- Last Posted Date
- 2016-09-15
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 221
- Registration Number
- NCT00274677
- Locations
- 🇺🇸
GSK Investigational Site, Houston, Texas, United States
Study In Asthma Control
- Conditions
- Asthma
- First Posted Date
- 2006-01-09
- Last Posted Date
- 2018-03-21
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 680
- Registration Number
- NCT00273026
- Locations
- 🇨🇦
GSK Investigational Site, Québec, Canada
Study With GW274150 In Patients With Mild Asthma
- First Posted Date
- 2006-01-09
- Last Posted Date
- 2017-10-18
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 28
- Registration Number
- NCT00273013
- Locations
- 🇬🇧
GSK Investigational Site, London, United Kingdom
COREG MR Versus TOPROL-XL On The Lipid Profile Of Normolipidemic Or Mildly Dyslipidemic Patients With Hypertension
- Conditions
- Hypertension
- Interventions
- First Posted Date
- 2006-01-09
- Last Posted Date
- 2018-06-25
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 514
- Registration Number
- NCT00273052
- Locations
- 🇵🇷
GSK Investigational Site, Rio Piedras, Puerto Rico
A Study Of A New Medicine (GW679769) For The Treatment Of Social Anxiety Disorder
- Conditions
- Anxiety DisordersSocial Anxiety Disorder
- First Posted Date
- 2006-01-09
- Last Posted Date
- 2016-10-26
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 242
- Registration Number
- NCT00273039
- Locations
- 🇲🇽
GSK Investigational Site, Mexico, D.F., Mexico